Reasons Given for Why the US Unable to Contain COVID-19
The MJH Life Sciences COVID-19 Coalition experts share their insights on the state of the pandemic.
The experts on the MJH Life Sciences COVID-19 Coalition are sharing their insights on the state of the pandemic and why the U.S. has been unable to contain it. MJH Life Sciences is the parent company of Infection Control Today®.
The top reasons given by the coalition members were widespread misinformation and lack of a comprehensive national strategy, both with 33.3 percent. Other reasons included lack of public health leadership, 22.2 percent, and other, with 11.1 percent.
The MJH Life Sciences COVID-19 Coalition is a partnership with 10 nationally recognized experts in infectious disease, public health, epidemiology, and virology, who work to generate the most accurate, up-to-the-minute information on the pandemic's ever-evolving impact on health care professionals and the patients they treat through live, biweekly webinar events, white papers, and surveys.
The next COVID-19 Coalition event, “Thinking Long-Term: COVID-19’s Clinical Consequences and Mental Health Effects,” will be held November 12, 2020, at 7:30PM ET. Register here.
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
